Skip to main content
Clinical Trials/IRCT20110802007202N15
IRCT20110802007202N15
Completed
Phase 3

Comparison of the effectiveness of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in adult patients

Tehran University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
36
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Attention Deficit Hyperactivity Disorder
  • Age between 19\-50 years
  • Signing consent form

Exclusion Criteria

  • Patients with a history of any systemic disorder such as cardiovascular diseases
  • Patients with a history of bipolar disorder, major depressive disorder, psychosis, substance abuse, pervasive developmental disorder and intellectual disability
  • Using psychotropic drugs within one month prior to the initiation of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials